ライフサイエンスコーパス: corticotropin

1 peptides melanocyte-stimulating hormone and corticotropin.

2 FSH)], with adrenocorticomelanotropic cells [corticotropin (ACTH) and alpha-melanotropin (alpha-MSH)]

3 in level and lack of stress- and cue-induced corticotropin and cortisol responses, higher anxiety, an

4 The production of corticotropin and cortisol was assessed in 11 specimens

5 ects of cortisol metabolism: daily levels of corticotropin and cortisol; plasma cortisol clearance, m

6 retion of cortisol suppresses the release of corticotropin by pituitary corticotrophs, which results

7 cronodular adrenal hyperplasia appears to be corticotropin-dependent.

8 ticotropin precursor proopiomelanocortin and corticotropin expression were assessed by means of a pol

9 rease <9 mug/dL after 250 mug of intravenous corticotropin from basal values <35 mug/dL.

10 lls: inositol polyphosphate-5-phosphatase A, corticotropin hormone precursor, ribosome biogenesis reg

11 A semiquantitative score for corticotropin immunostaining in the samples correlated w

12 We examined the abnormal production of corticotropin in these hyperplastic adrenal glands.

13 Corticotropin-independent Cushing's syndrome is caused b

14 Some cases of corticotropin-independent macronodular adrenal hyperplas

15 Transcriptome-based classification of corticotropin-independent macronodular adrenal hyperplas

16 Thus, the disease has been termed corticotropin-independent macronodular adrenal hyperplas

17 Corticotropin-independent macronodular adrenal hyperplas

18 and tumor DNA obtained from 33 patients with corticotropin-independent macronodular adrenal hyperplas

19 A axis dysregulation, marked by higher basal corticotropin level and lack of stress- and cue-induced

20 Serum and salivary cortisol and plasma corticotropin levels decreased, and clinical signs and s

21 However, low corticotropin levels have also been reported in critical

22 Adrenal corticotropin levels were higher in adrenal venous blood

23 er in the patients than in controls, whereas corticotropin levels were lower (P<0.001 for both compar

24 Corticotropin levels were measured in adrenal and periph

25 y corticotrophs, which results in low plasma corticotropin levels.

26 The corticotropin precursor proopiomelanocortin and corticot

27 d greater neutral, relaxed-state cortisol to corticotropin ratio (adrenal sensitivity) were each pred

28 Corticotropin-receptor antagonists significantly inhibit

29 gh an interaction between the stress hormone corticotropin releasing factor (CRF) and glutamate relea

30 The stress neuropeptide corticotropin releasing factor (CRF) and its receptors (

31 Corticotropin releasing factor (CRF) coordinates the bra

32 Here we demonstrate that, in the vBNST, corticotropin releasing factor (CRF) is expressed in neu

33 Corticotropin releasing factor (CRF) is the primary medi

34 of this study was to examine the ability of corticotropin releasing factor (CRF) or antibody to insu

35 Corticotropin releasing factor (CRF) plays a major role

36 icotine withdrawal was mediated by increased corticotropin releasing factor (CRF) receptor-1 expressi

37 Corticotropin releasing factor (CRF) regulates physiolog

38 lar nucleus (PVN) have been shown to inhibit corticotropin releasing factor (CRF) synthesis via GABA(

39 The corticotropin releasing factor (CRF) system in the centr

40 The corticotropin releasing factor (CRF) system in the centr

41 Corticotropin releasing factor (CRF) within the ventral

42 ontains a large number of neurons expressing corticotropin releasing factor (CRF), a neuropeptide tha

43 Urocortin 1 (Ucn 1) is an endogenous corticotropin releasing factor (CRF)-related peptide.

44 presence of the prototypical stress hormone, corticotropin releasing factor (CRF).

45 of action for the anxiogenic neuromodulator, corticotropin releasing factor (CRF).

46 ine seeking by the stress-sensitive peptide, corticotropin releasing factor (CRF).

47 The mammalian corticotropin releasing factor (CRF)/urocortin (Ucn) pep

48 he transmembrane domains of the glucagon and corticotropin releasing factor 1 (CRF1) receptors to dev

49 Corticotropin releasing factor binding protein (CRF-BP)

50 oupled receptors, which bind peptides of the corticotropin releasing factor family and are key mediat

51 technique to a member of a class B GPCR, the corticotropin releasing factor receptor 1 (CRF1R).

52 analysis showed significant upregulation of corticotropin releasing factor receptor 2 (CrfR2) in the

53 The current study examines the role of corticotropin releasing factor receptor subtypes 1 and 2

54 nvestigated here the interaction between the corticotropin releasing factor receptor type 1 (CRF1R) a

55 tuted pyridyl)pyrazolo[1,5-a]-1,3,5-triazine corticotropin releasing factor receptor-1 (CRF(1)) recep

56 Corticotropin releasing factor type 1 (CRF1) is a key co

57 in stress and appetite regulation, including corticotropin releasing factor, pro-opiomelanocortin B,

58 88-induced c-Fos activation were observed in corticotropin releasing factor-containing neurons of the

59 eus of the hypothalamus and primarily in non-corticotropin releasing factor-containing neurons of the

60 rmones and is transcriptionally activated in corticotropin releasing factor-expressing cells.

61 ORs that colocalize with the stress hormone, corticotropin releasing factor.

62 ional interaction between macroautophagy and Corticotropin Releasing Hormone (Crh) in the gut.

63 Intra-amygdala CORT or intra-LC corticotropin releasing hormone (CRH) infusion supported

64 Corticotropin releasing hormone (CRH) is disrupted in in

65 nt male and female offspring received either corticotropin releasing hormone (CRH) or saline intraven

66 al requires Nmu receptor 2 and signaling via corticotropin releasing hormone (Crh) receptor 1.

67 Glucocorticoids and corticotropin releasing hormone (CRH) underlie the physi

68 ethylation of the cortisol-regulating genes, corticotropin releasing hormone (CRH; P=0.05) and glucoc

69 from the nucleus tractus solitarii (NTS) to corticotropin releasing hormone neurons in the paraventr

70 erone levels), and alleviated by antalarmin (corticotropin releasing hormone receptor 1 antagonist).

71 cluding the membrane progestin receptor, the corticotropin releasing hormone receptor, and the 5HT1a

72 ding glutamate, acetylcholine, somatostatin, corticotropin releasing hormone, and nitric oxide.

73 oked robust upregulation of cholecystokinin, corticotropin releasing hormone, galanin, neuropeptide Y

74 Using a corticotropin releasing hormone-cre driver X tdTomato re

75 The corticotropin releasing hormone-related ligand, urocorti

76 were measured at baseline and in response to corticotropin-releasing factor (CRF) (0.5 microg kg(1))

77 We report that corticotropin-releasing factor (CRF) acts in the ventral

78 Although it has long been known that corticotropin-releasing factor (CRF) and CRF receptors a

79 mRNA was found to partially colocalize with corticotropin-releasing factor (CRF) and growth hormone-

80 Corticotropin-releasing factor (CRF) and nociceptin/orph

81 laced on the neuropharmacological actions of corticotropin-releasing factor (CRF) and norepinephrine

82 Release of the neuropeptides corticotropin-releasing factor (CRF) and orexin-A in the

83 Here we report the identification of corticotropin-releasing factor (CRF) as a critical compo

84 s-induced release of neuromodulators such as corticotropin-releasing factor (CRF) can drive drug-depe

85 To investigate corticotropin-releasing factor (CRF) contributions to fe

86 regulation of the central extrahypothalamic corticotropin-releasing factor (CRF) expression is assoc

87 The corticotropin-releasing factor (CRF) family of peptides

88 Urocortin 2 (Ucn2), a peptide of the corticotropin-releasing factor (CRF) family, binds with

89 hypersecretion of the stress neuromediator, corticotropin-releasing factor (CRF) has been implicated

90 rofiling of relevant PI cells identified the corticotropin-releasing factor (CRF) homolog, DH44, as a

91 ike ShA cocaine self-administration, reduced corticotropin-releasing factor (CRF) immunodensity in th

92 ed body of work indicates a crucial role for corticotropin-releasing factor (CRF) in neurobiological

93 termined the role of the stress neurohormone corticotropin-releasing factor (CRF) in stress-induced b

94 ed on previous work hypothesizing a role for corticotropin-releasing factor (CRF) in the IC during cr

95 lores the relationship between dynorphin and corticotropin-releasing factor (CRF) in the induction of

96 bout the distribution of the stress hormone, corticotropin-releasing factor (CRF) in the mouse brain.

97 We recently described the existence of corticotropin-releasing factor (CRF) in the mouse cochle

98 literature suggests that catecholamines and corticotropin-releasing factor (CRF) interact in a seria

99 Corticotropin-releasing factor (CRF) is an important lin

100 Corticotropin-releasing factor (CRF) is critical for the

101 Corticotropin-releasing factor (CRF) is expressed in the

102 Corticotropin-releasing factor (CRF) mediates anxiogenic

103 Corticotropin-releasing factor (CRF) mRNA expression in

104 and anxiety and activates a subpopulation of corticotropin-releasing factor (CRF) neurons in the bed

105 cohol intake specifically recruited GABA and corticotropin-releasing factor (CRF) neurons in the mPFC

106 the relationship between corticosterone and corticotropin-releasing factor (CRF) on both beta-amyloi

107 ed the effect of an intravenous injection of corticotropin-releasing factor (CRF) on fructose malabso

108 nced fear memory but did not increase either corticotropin-releasing factor (CRF) or corticosterone.

109 Corticotropin-releasing factor (CRF) orchestrates the st

110 The corticotropin-releasing factor (CRF) peptide hormone fam

111 Considerable evidence suggests that corticotropin-releasing factor (CRF) plays an important

112 The corticotropin-releasing factor (CRF) receptor 1 (CRFR1)

113 duction and Abeta elevation are dependent on corticotropin-releasing factor (CRF) receptor 1 signalin

114 Corticotropin-releasing factor (CRF) receptors are found

115 Because corticotropin-releasing factor (CRF) receptors are impli

116 ife social isolation increases the levels of corticotropin-releasing factor (CRF) receptors in the se

117 Corticotropin-releasing factor (CRF) receptors-which bin

118 The stress-related neuropeptide, corticotropin-releasing factor (CRF) regulates the dorsa

119 induced relapse through alterations in brain corticotropin-releasing factor (CRF) regulation of neuro

120 Corticotropin-releasing factor (CRF) signaling at the CR

121 Alterations in corticotropin-releasing factor (CRF) signaling pathways

122 Dysregulation of the corticotropin-releasing factor (CRF) system has been imp

123 The corticotropin-releasing factor (CRF) system, which is in

124 f neonatal amygdala (Neo-A) lesions on brain corticotropin-releasing factor (CRF) systems and hypotha

125 The corticotropin-releasing factor (CRF) type 1 receptor (CR

126 Systemic blockade of corticotropin-releasing factor (CRF) type 1 receptors (C

127 Here we report that corticotropin-releasing factor (CRF), a neuropeptide rel

128 nsistent with this, the CEA highly expresses corticotropin-releasing factor (CRF), an important modul

129 (Dh44), a neuropeptide related to vertebrate corticotropin-releasing factor (CRF), and its receptor,

130 The neuroactive substances corticotropin-releasing factor (CRF), arginine-vasopress

131 to the BNSTDL, is thought to communicate via corticotropin-releasing factor (CRF), but studies have y

132 The neuropeptide, corticotropin-releasing factor (CRF), coordinates the ph

133 Corticotropin-releasing factor (CRF), encoded by the CRH

134 ological studies indicate the involvement of corticotropin-releasing factor (CRF), noradrenaline, dop

135 Corticotropin-releasing factor (CRF), originally charact

136 Corticotropin-releasing factor (CRF), the major stress p

137 The focus is on the receptor for corticotropin-releasing factor (CRF), the orchestrator o

138 Corticotropin-releasing factor (CRF), the stress-related

139 ral amygdala noradrenergic substrates [via a corticotropin-releasing factor (CRF)-dependent mechanism

140 allenge has been shown previously to cause a corticotropin-releasing factor (CRF)-mediated increase i

141 Corticotropin-releasing factor (CRF)-mediated mechanisms

142 ation of VTA dopaminergic neurons expressing corticotropin-releasing factor (CRF).

143 ) system by the stress-related neuropeptide, corticotropin-releasing factor (CRF).

144 amygdala (CeA) that produce the neuropeptide corticotropin-releasing factor (CRF).

145 agonists for the stress-related neurohormone corticotropin-releasing factor (CRF).

146 d reward, including neuropeptide Y (NPY) and corticotropin-releasing factor (CRF).

147 vation of glucocorticoid receptors (GRs) and corticotropin-releasing factor (CRF).

148 This study tested the hypothesis that the corticotropin-releasing factor (CRF1) antagonist GSK5616

149 ist (eticlopride), D2R agonist (quinpirole), corticotropin-releasing factor 1 (CRF1) antagonist (anta

150 urthermore, pharmacologic inhibition (with a corticotropin-releasing factor 1 receptor antagonist) of

151 t of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neu

152 alcohol drinking by increased expression of corticotropin-releasing factor and its feedback regulati

153 ed with brain region-specific alterations of corticotropin-releasing factor expression and promoter m

154 The neuropeptides vasopressin and corticotropin-releasing factor facilitate, while seroton

155 fashion both NGF and the hormone urotensin (corticotropin-releasing factor family ligand).

156 ephalin, thyrothropin-releasing hormone, and corticotropin-releasing factor immunoreactive cells in t

157 Corticotropin-releasing factor infusions into LA impair

158 Corticotropin-releasing factor infusions into the centra

159 s in the anterior hypothalamus that may gate corticotropin-releasing factor output from the amygdala

160 ss, the physiological consequence of central corticotropin-releasing factor receptor (CRF-R) activati

161 viously reported differential involvement of corticotropin-releasing factor receptor (CRFR) 1 and 2 i

162 Administration of the selective corticotropin-releasing factor receptor 1 (CRF(1)) antag

163 In addition, we examined the role of the corticotropin-releasing factor receptor 1 (CRF(1)) in th

164 We aimed to characterize the effects of the corticotropin-releasing factor receptor 1 (CRF-R1) antag

165 noradrenergic (NE) receptors (alpha1) via a corticotropin-releasing factor receptor 1 (CRF-R1)-depen

166 rial evaluating the efficacy of GSK561679, a corticotropin-releasing factor receptor 1 (CRF1 receptor

167 Blockade of corticotropin-releasing factor receptor 1 (CRF1) suppres

168 Similarly to what has been observed for the corticotropin-releasing factor receptor 1 (CRFR1), SAP97

169 me proliferator-activated receptor gamma and corticotropin-releasing factor receptor 1 were notable e

170 ecifically activated by either neurokinin I, corticotropin-releasing factor receptor 1, or dopamine D

171 mutants with constitutive activation of the corticotropin-releasing factor receptor family homologue

172 d, we took the CRF(2(a))R and the homologous corticotropin-releasing factor receptor type 1 (CRF(1)R)

173 esent study investigated whether blockade of corticotropin-releasing factor receptor type 1 (CRF-R1)

174 n reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) po

175 we investigated interactions of the class B corticotropin-releasing factor receptor type 1 (CRF1R) w

176 Corticotropin-releasing factor receptor type 1 (CRFR1) i

177 ular membrane compartments, we show that the corticotropin-releasing factor receptor type 1 has a spe

178 ure of the transmembrane domain of the human corticotropin-releasing factor receptor type 1 in comple

179 The corticotropin-releasing factor receptor type 1 is a clas

180 here this equilibrium is established for the corticotropin-releasing factor receptor type 1.

181 vation of the central stress response, while corticotropin-releasing factor receptor type 2 (CRFR2) h

182 Corticotropin-releasing factor receptor type 2 (CRFR2) h

183 eviously, we observed abnormal expression of corticotropin-releasing factor receptor type 2 (CRFR2) t

184 The corticotropin-releasing factor receptor type 2a (CRF(2(a

185 Corticotropin-releasing factor receptor-1 (CRF(1)) media

186 n in the BNST is unaffected by alpha1-AR and corticotropin-releasing factor receptor-1 (CRFR(1)) anta

187 Effects on attention were attenuated by the corticotropin-releasing factor receptor-1 antagonist ant

188 Corticotropin-Releasing Factor Receptors (CRFRs) are cla

189 Corticotropin-releasing factor receptors (CRFRs), class

190 Alterations in central corticotropin-releasing factor signaling pathways have b

191 ry-adrenal axis), (4) the (gastrointestinal) corticotropin-releasing factor system, and (5) the intes

192 In addition, corticotropin-releasing factor systems were shown to fac

193 is function was probed using a dexamethasone/corticotropin-releasing factor test.

194 Activation of corticotropin-releasing factor type 1 (CRF1) receptors i

195 icated that repeated social stress decreased corticotropin-releasing factor type 1 receptor and incre

196 We found that corticotropin-releasing factor type 1 receptor within th

197 disrupts this LTCC-based mechanism; instead, corticotropin-releasing factor type 1 receptors (CRF1s)

198 disrupts this LTCC-based mechanism; instead, corticotropin-releasing factor type 1 receptors (CRF1s)

199 The corticotropin-releasing factor type 2 receptor (CRFR2) i

200 demonstrated that the mechanism involved the corticotropin-releasing factor type 2 receptor, cAMP ele

201 n the amygdala, which required activation of corticotropin-releasing factor type-1 (CRF-R1) receptors

202 cial behavior (especially neuropeptide Y and corticotropin-releasing factor) are modulated by alcohol

203 Corticotropin-releasing factor, a stress-related neurope

204 tuitary-adrenal axis, including signaling by corticotropin-releasing factor, in the pathophysiology o

205 w stress interacts with the neuromodulators, corticotropin-releasing factor, norepinephrine, dopamine

206 ess effect by counteracting the functions of corticotropin-releasing factor, the primary stress-media

207 peptides (ghrelin, nesfatin-1, somatostatin, corticotropin-releasing factor, thyrotropin-releasing ho

208 known as maternal aggression) is impaired by corticotropin-releasing factor-(CRF) related peptides, b

209 s was identified as potent and orally active corticotropin-releasing factor-1 (CRF(1)) receptor antag

210 ctive withdrawal-like state characterized by corticotropin-releasing factor-1 (CRF(1)) receptor antag

211 rmittent access to palatable food results in corticotropin-releasing factor-1 (CRF1) receptor antagon

212 e diuretic hormone 44 (DH44), an ortholog of corticotropin-releasing factor.

213 They further suggest that an activated corticotropin-releasing factor/hypothalamic-pituitary-ad

214 luding those that encode the stress hormones corticotropin-releasing hormone (CRH) and adrenocorticot

215 The corticotropin-releasing hormone (CRH) and its type 1 rec

216 n-33 (IL-33), and stress molecules including corticotropin-releasing hormone (CRH) and neurotensin (N

217 s been postulated that altered expression of corticotropin-releasing hormone (CRH) can at least parti

218 larval zebrafish with transgenically labeled corticotropin-releasing hormone (CRH) cells, which repre

219 employed viral-genetic approaches to reduce corticotropin-releasing hormone (Crh) expression in the

220 tress promotes secretion of the neuropeptide corticotropin-releasing hormone (CRH) from hippocampal i

221 axis initiates the production and release of corticotropin-releasing hormone (CRH) from the paraventr

222 activity for the suppression of hypothalamic corticotropin-releasing hormone (CRH) gene expression an

223 of the expression of the stress neurohormone corticotropin-releasing hormone (CRH) in hypothalamic ne

224 nstrate that a cluster of neurons expressing corticotropin-releasing hormone (Crh) in the pontine mic

225 Corticotropin-releasing hormone (CRH) is a central integ

226 Corticotropin-releasing hormone (CRH) is a major regulat

227 Corticotropin-releasing hormone (CRH) is secreted under

228 Corticotropin-releasing hormone (CRH) is suggested to be

229 Here we demonstrate that corticotropin-releasing hormone (CRH) neurons are modula

230 affects excitatory and inhibitory inputs to corticotropin-releasing hormone (CRH) neurons in the hyp

231 Corticotropin-releasing hormone (CRH) neurons in the par

232 tical areas transmit signals to hypothalamic corticotropin-releasing hormone (CRH) neurons, which con

233 augments excitatory synaptic strength in PVN corticotropin-releasing hormone (CRH) neurons, with GLP-

234 el synergistic actions of corticosterone and corticotropin-releasing hormone (CRH) on synaptic physio

235 ing hormone, oxytocin, arginine vasopressin, corticotropin-releasing hormone (CRH) or thyrotropin-rel

236 ress, adrenal corticosterone and hippocampal corticotropin-releasing hormone (CRH) permeate memory-fo

237 g-standing paradigm posits that hypothalamic corticotropin-releasing hormone (CRH) regulates neuroend

238 Corticotropin-releasing hormone (CRH) released from the

239 The corticotropin-releasing hormone (CRH) system coordinates

240 In addition, increased activation of the corticotropin-releasing hormone (CRH) system within the

241 working memory (WM) deficits; changes to the corticotropin-releasing hormone (CRH) system; and struct

242 e production and release of the neuropeptide corticotropin-releasing hormone (CRH) within the hippoca

243 n the underlying mechanisms, but the role of corticotropin-releasing hormone (CRH), a hypothalamic ho

244 Extensive preclinical data implicate corticotropin-releasing hormone (CRH), acting through it

245 Although corticotropin-releasing hormone (CRH), produced by parvo

246 Corticotropin-releasing hormone (CRH), through the hypot

247 nals were collected and processed to measure corticotropin-releasing hormone (CRH), urocortin (Ucn),

248 activities by stimulating the expression of corticotropin-releasing hormone (CRH), urocortin, proopi

249 multilabeled for vasotocin, mesotocin (MT), corticotropin-releasing hormone (CRH), vasoactive intest

250 ormone 44 (Dh44), a homolog of the mammalian corticotropin-releasing hormone (CRH), were specifically

251 ticoids and the stress-released neuropeptide corticotropin-releasing hormone (CRH), which influence t

252 evious studies have described the effects of corticotropin-releasing hormone (CRH), which is released

253 he adult brain, we have virally traced local corticotropin-releasing hormone (CRH)-expressing inhibit

254 noreactive boutons in apposition to both the corticotropin-releasing hormone (CRH)-immunoreactive cel

255 ed subset of OXT neurons that co-express the corticotropin-releasing hormone (CRH).

256 nced vertebrate genomes for genes resembling corticotropin-releasing hormone (CRH).

257 A possible link between placental corticotropin-releasing hormone (pCRH) and PPD incidence

258 al stress physiology, specifically placental corticotropin-releasing hormone (pCRH).

259 found that the rs28365143 variant within the corticotropin-releasing hormone binding protein (CRHBP)

260 The corticotropin-releasing hormone family mediates function

261 MNL-CMR-associated PTD showed higher CRP and corticotropin-releasing hormone levels.

262 ds of aberrant membrane receptors but not by corticotropin-releasing hormone or dexamethasone.

263 The type 1 corticotropin-releasing hormone receptor (CRH-R1) influe

264 e other ligand-binding site defined--for the corticotropin-releasing hormone receptor 1 (CRF1R)--whic

265 Corticotropin-releasing hormone receptor 1 (CRHR1) activ

266 Variations in the corticotropin-releasing hormone receptor 1 (CRHR1) gene

267 In addition, GR and corticotropin-releasing hormone receptor 1 (CRHR1) genot

268 ment interaction in which a haplotype in the corticotropin-releasing hormone receptor 1 gene (CRHR1)

269 elch-like protein 2)), chromosome 17 (CRHR1 (corticotropin-releasing hormone receptor 1) and MAPT (mi

270 Activation of corticotropin-releasing hormone receptor 2 (CRHR2) in th

271 5-2 muM) for 6 hours significantly increases corticotropin-releasing hormone receptor-1 (CRHR-1) mRNA

272 found a significant three-way interaction on corticotropin-releasing hormone receptor-1 (Crhr1) gene

273 bellar Purkinje cells, and co-localized with corticotropin-releasing hormone receptors in the latter.

274 stress-coping responses by binding to type 2 corticotropin-releasing hormone receptors.

275 in both the initial and replication samples: corticotropin-releasing hormone signaling, cardiac beta-

276 l enrichment analyses revealed enrichment of corticotropin-releasing hormone signaling, GNRH signalin

277 y outcomes, including repeated dexamethasone-corticotropin-releasing hormone tests, and psychiatric r

278 a indicate that genetic variation within the corticotropin-releasing hormone type 1 receptor gene (CR

279 Furthermore, endogenous corticotropin-releasing hormone(+) (CRH(+)) LC inputs fr

280 way in rat paraventricular hypothalamic CRH (corticotropin-releasing hormone) neuroendocrine neurons

281 CRH (corticotropin-releasing hormone), a peptide released fro

282 ernal blood (i.e., C-reactive protein (CRP), corticotropin-releasing hormone, and cytokines) were com

283 at several peptide markers (cholecystokinin, corticotropin-releasing hormone, and tachykinin 1) label

284 the pathogenesis of IBD include substance P, corticotropin-releasing hormone, neurotensin, and vasoac

285 not GABAergic, and do not express oxytocin, corticotropin-releasing hormone, vasopressin, or prodyno

286 In addition, we discovered that corticotropin-releasing hormone-expressing cells contain

287 al raphe-originating serotonergic control of corticotropin-releasing hormone-mediated excitation of t

288 refrontal cortex restrains the amygdala, the corticotropin-releasing hormone/hypothalamic-pituitary-a

289 We demonstrate that corticotropin-releasing-hormone-binding protein (CRHBP),

290 The corticotropin response to CRH was independent of sex and

291 ts potential use as a targeted treatment for corticotropin-secreting pituitary adenomas.

292 We evaluated adrenal function using short corticotropin stimulation test in 157 episodes of gastro

293 We evaluated adrenal function using short corticotropin stimulation test in patients with cirrhosi

294 correlated with a lower cortisol response to corticotropin stimulation.

295 , contributed to hypercortisolemia and hence corticotropin suppression.

296 Corticotropin was detected in steroidogenic cells arrang

297 The cortisol response to corticotropin was inversely correlated with Model for En

298 The release of adrenal corticotropin was stimulated by ligands of aberrant memb

299 Cortisol and corticotropin were positively correlated in the controls

300 ushing's syndrome appears to be regulated by corticotropin, which is produced by a subpopulation of s